Safety and Immunogenicity of a PHH-1V Booster Dose after Different Prime Vaccination Schemes against Covid-19: Phase III Clinical Trial Final Results Up To One Year. Archives of Clinical and Biomedical Research, v. 8, n. 4, p. 326–342, 6 Aug.2024.